Skip to main content
MACPAC wants states to have more time to make drug coverage decisions
4/12/2019

The Medicaid and CHIP Payment and Access Commission agreed to recommend that Congress give states a 180-day grace period to evaluate a new drug's effectiveness before deciding whether to cover that drug. The commission's members also want lawmakers to eliminate a cap on Medicaid drug rebates.

Full Story: